Up-regulated genes due to the down-regulation of microRNAs by EGF, bFGF, and IGF-1 treatment were predicted to target EGFR, FGFR, and IGFR, respectively, via cytokine-cytokine receptor interaction in the cancer pathway. This evidence concerns the gene EGFR and cancer.